Stay updated on 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial
Sign up to get notified when there's something new on the 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial page.

Latest updates to the 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial page
- Check5 days agoChange DetectedA new revision entry v3.4.3 was added to the record history. The previous revision v3.4.2 was removed from the history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedTelix is conducting a separate Phase 3 trial (NCT06520345) under an IND, which necessitates the closure of the current 177Lu-TLX591-002 Phase 3 trial. The record now shows the study as Terminated and indicates that the prior Recruiting status was removed.SummaryDifference1.0%

- Check34 days agoChange DetectedNew system Revision: v3.4.2 has been added to the record history, and the prior government funding lapse notice has been removed.SummaryDifference0.9%

- Check41 days agoChange DetectedA site-wide notice about government funding and an updated Revision: v3.4.1 were added, and the previous Revision: v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check48 days agoChange DetectedUI/formatting updates on the Record History page include a glossary toggle, color-coded highlights for additions and deletions, and a new version label (v3.4.0) replacing the previous (v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check62 days agoChange DetectedThe Record History now shows a new revision entry: v3.3.4, replacing the previous v3.3.3 entry.SummaryDifference0.1%

Stay in the know with updates to 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial page.